|
- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis
% r8 L+ v' g- {2 S7 J/ f |9 bwas to close its brain research facility in Basel, Switzerland,
8 X+ s! i5 W& c, }9 ethe story noted that this move closely followed similar cuts
9 I* P* O- P" vby rival pharmaceutical firms. As a report from the European College! E# b7 g8 y, l, ]2 o+ O, v. i
of Neuropsychopharmacology6 [6 R8 h9 a( Z6 K/ A/ C
had warned a few months earlier, the
1 a& t# A# ], V5 ]abandonment of research into new psychiatric drugs by AstraZeneca, S1 h5 f" b) I4 m- @3 t$ F* N
GlaxoSmithKline/ d5 _- V" B2 T7 c0 E9 O
and others meant that “withdrawal of research8 N* R" ^: a0 j8 E
resources is a withdrawal of hope for patients and their families”.
) d( d, b$ ?; S E+ j: [- A4 y
2 a+ v: P) e4 x: d2 K' N
回复有免费下载链接
+ }9 }' O+ x( V) d9 b. K# C! |' b
w0 }5 ^1 M' | |
-
总评分: 包包 + 20
查看全部评分
|
发表于 2013-10-12 08:22
发表于 2013-10-12 08:44
